{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:57:39Z","timestamp":1793476659498,"version":"4.5.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"17","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2018,5,22]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> Cantharidin has been categorized as highly toxicant in Chinese medicine. But\ncantharidin can efficiently treat different types of diseases, such as molluscum contagiosum. While\ncantharidin is quite useful, unfortunately, due to its side effects, increasing regulations have limited\naccess to this useful therapeutic option. Cantharidin's toxic effects have caused it to fall into disuse for\nmost legitimate medical purposes. Although cantharidin generates effects and its advantages must be\nrealized. Recently, cancer affects people\u2019s life more and more. Because cantharidin can treat some cancers,\nso solutions must be used to reduce side effects. This review aims to describe some its analogues,\nseveral efficient methods to inhibit the side effects of cantharidin and pharmacogenomics of cantharidin.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> We searched for research about cantharidin by entering the database. Then evaluated these\npapers and analyzed their founding, solution, mechanism, etc., and targeted to screen the papers related\nto the content of our research, and then sorted them out in accordance with the solution, mechanism\nresearch and other content. Finally, these content was unified into a framework.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> Some cantharidin's analogues were found that they show some similar functions to cantharidin\nand we found that norcantharidin, acylthiourea derivatives, cantharidinamides, anhydride-modified\nderivatives and other derivatives have less side effects. The modified cantharidin analogues reduce\ntoxicity in hepatocytes. Cantharidin consists of a six-ring and a five-ring, the moiety of oxygen on the\nsix-ring and the anhydride section exhibit biochemical activity. Protein phosphatases are associated\nwith many cellular processes including apoptosis, cell cycle progression and so on. Cantharidin can\ncause apoptosis and double-stand breakage of DNA. Cantharidin and norcantharidin can efficiently\ninhibit the activity of mammalian and plant protein phosphatase 1 (PP1) and protein phosphatase 2A\n(PP2A) in vivo. Cantharidin inhibits PP5 at the nanomolar level with an IC50 value of 600 nM. PP5 can\nmanage the cellular survival, death, proliferation and other some intracellular biological activities in\nmammals. After cantharidin\u2019s treatment, the level of EtPP5 mRNA expression was downregulated.\nTheir also can be used to inhibit the Glutathione S-transferases (GSTs), angiogenesis and the expression\nof A549 human lung cancer cells, trigger eryptosis and induced bladder cancer cell apoptosis. We\nfound that using Vitamin C and ginsenosides and translating cantharidin into nanoparticles can minimize\nthe cantharidin side effects in the patients.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Cantharidin can inhibit various tumor cell lines. Cantharidin causes both DNA single- and\ndouble- strand breaks and induces apoptosis. Although cantharidin shows some toxicity for human, its\nanti-cancer effects should be taken seriously. Several viable methods can help solve this problem. The\nmost important pharmacogenomics of cantharidin is that cantharidin can inhibit PPs, because PPs are\nassociated with many cellular processes. This prospect is very broad and needs to continue studying.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867324666170414165253","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T08:53:17Z","timestamp":1526979197000},"page":"2034-2044","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["Overview of Cantharidin and its Analogues"],"prefix":"10.2174","volume":"25","author":[{"given":"Guofang","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Chemistry and Chemical Engineering, Shaoxing University, Shaoxing 312000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Chemical Engineering, Shaoxing University, Shaoxing 312000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Chemical Engineering, Shaoxing University, Shaoxing 312000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/151633","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/151633\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/151633","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T09:58:36Z","timestamp":1608890316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/151633\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":0,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2018,5,22]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867324666170414165253","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5,22]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2016-09-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-03-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-04-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}